Results 81 to 90 of about 1,327 (120)

Breast surgery and systemic treatment continuation for patients with de novo metastatic breast cancer and locoregional oligoprogression: a cohort study. [PDF]

ESMO Open
Valenza C, Bianco N, Milano M, Trapani D, Di Bella S, Sciandivasci A, Minchella I, Sangalli C, Galimberti V, Intra M, Veronesi P, Munzone E, Colleoni M, Curigliano G.   +13 more
europepmc   +1 more source

Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology. [PDF]

J Pers Med
Ferini G, Forte S.
europepmc   +1 more source

Acquired TPM3::NTRK1 fusion as a novel off-target resistance mechanism to selpercatinib in RET-positive lung adenocarcinoma: a case report. [PDF]

Front Oncol
Choudhury R, Sharma M, Dewan A, Choudhary SK, Venkatraman P, Subbiah V, Batra U.   +6 more
europepmc   +1 more source

Rethinking Immunotherapy Resistance in Melanoma: A Narrative Review of Clinical Patterns, Resistance Mechanisms, and Future Strategies. [PDF]

Cancers (Basel)
Ghais A, Rizkallah J, Wehbeh BED, Diab Y, Awada A, Atwi M, Ayoub R, Mina C, Rammal F, Badr A, Faraj S, Charbel N, Kreidieh F.   +12 more
europepmc   +1 more source

Case Report: MR-guided adaptive stereotactic body radiotherapy for splenic metastases: a case series of technical feasibility and early clinical outcomes. [PDF]

Front Oncol
Tan D, Edwards L, Byrne HL, Liang T, Biggerstaff K, Leong E, Lim T, Rahim K, Tan H.   +8 more
europepmc   +1 more source

Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab. [PDF]

BMC Cancer
Saray S, Engin B, Kadıoğlu A, Akın M, Kanmaz H, İriağaç Y.   +5 more
europepmc   +1 more source

Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity. [PDF]

Int J Mol Sci
Scaglione IM, Bonato A, Dodi A, Sposito M, Eccher S, Avancini A, Tregnago D, Insolda J, Milella M, Pilotto S, Belluomini L.   +10 more
europepmc   +1 more source

Maximizing survival benefit with precision therapy based on progressive patterns after immunochemotherapy in metastatic esophageal cancer. [PDF]

iScience
Liu Y, Cheng S, Dong T, Li B, Jiang C, Yu J, Wang L.   +6 more
europepmc   +1 more source

Long-Term Survival Achieved by Combined Surgical Resection and Immunotherapy for Recurrent Adrenal Oligometastasis of Lung Adenocarcinoma: A Case Study. [PDF]

Cureus
Hasegawa S, Kiwamoto T, Aida Y, Shiozawa T, Hizawa N.   +4 more
europepmc   +1 more source